In cases of acquired non-tumoral GHD resulting from conditions such as severe brain trauma, lymphocytic hypophysitis, sarcoidosis, or Langerhans cell histiocytosis, continuation of GH therapy is indicated, particularly in MPHD (47, 48). Here, GH1 is linked to injury.